Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
NovaBay Pharmaceuticals Inc
NBYCurrent price
0.7 USD
-0.03 USD (-4.09%)
Last closed
0.72 USD
Company
www.novabay.com
ISIN
US66987P2011
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Capitalization
3 664 267 USD
Yield for 12 month
-93.95 %
1Y
3Y
5Y
10Y
15Y
NBY
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. Address: 2000 Powell Street, Emeryville, CA, United States, 94608
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.3 USDP/E ratio
–Dividend Yield
–Current Year
+14 726 000 USD
Last Year
+14 404 000 USD
Current Quarter
+2 400 000 USD
Last Quarter
+2 631 000 USD
Current Year
+7 895 000 USD
Last Year
+7 781 000 USD
Current Quarter
+1 592 000 USD
Last Quarter
+1 794 000 USD
Key Figures NBY
1 year
3 years
5 years
10 years
EBITDA
-5 031 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-32.8 %
PEG Ratio
–
Return On Equity TTM
-282.96 %
Wall Street Target Price
7.3 USD
Revenue TTM
13 884 000 USD
Book Value
-0.46 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-32.1 %
Dividend Yield
–
Gross Profit TTM
5 645 000 USD
Earnings per share
-76.04 USD
Diluted Eps TTM
-76.04 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-76.81 %
Dividend Analytics NBY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NBY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:35
Payout Ratio
–
Last Split Date
31.05.2024
Dividend Date
–
Stock Valuation NBY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.355
Price Sales TTM
0.2639
Enterprise Value EBITDA
-0.3449
Price Book MRQ
0.2883
Financials NBY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NBY
For 52 weeks
0.36 USD
12.77 USD
50 Day MA
0.6 USD
Shares Short Prior Month
126 673
200 Day MA
2.65 USD
Short Ratio
–
Shares Short
17 887
Short Percent
0.37 %
BeatStart